Novartis AG annual current ratio
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Novartis AG Current Ratio Growth & History (NVS)
Novartis AG's current ratio was 1.12 for fiscal 2025.
View full Novartis AG company overviewNovartis AG annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.12 | 0.08 | +7.86% |
| 2024 | 2024-12-31 | 1.04 | −0.12 | −10.37% |
| 2023 | 2023-12-31 | 1.16 | −0.13 | −10.33% |
| 2022 | 2022-12-31 | 1.29 | −0.23 | −14.89% |
| 2021 | 2021-12-31 | 1.51 | 0.62 | +68.61% |
| 2020 | 2020-12-31 | 0.90 | −0.15 | −14.01% |
| 2019 | 2019-12-31 | 1.04 | −0.16 | −13.10% |
| 2018 | 2018-12-31 | 1.20 | −0.00 | −0.34% |
| 2017 | 2017-12-31 | 1.21 | 0.08 | +7.37% |
| 2016 | 2016-12-31 | 1.12 | — | — |
Novartis AG quarterly current ratio
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.86 | 0.04 | +5.33% |
| Q1 2026 | 2026-03-31 | 0.85 | — | — |
| Q4 2025 | 2025-12-31 | 1.12 | 0.08 | +7.86% |
| Q3 2025 | 2025-09-30 | 0.88 | — | — |
| Q2 2025 | 2025-06-30 | 0.82 | −0.11 | −12.10% |
| Q4 2024 | 2024-12-31 | 1.04 | −0.12 | −10.37% |
| Q2 2024 | 2024-06-30 | 0.93 | −0.12 | −11.35% |
| Q4 2023 | 2023-12-31 | 1.16 | −0.13 | −10.33% |
| Q2 2023 | 2023-06-30 | 1.05 | −0.33 | −23.92% |
| Q4 2022 | 2022-12-31 | 1.29 | −0.23 | −14.89% |
| Q2 2022 | 2022-06-30 | 1.38 | 0.58 | +71.72% |
| Q4 2021 | 2021-12-31 | 1.51 | 0.62 | +68.61% |
| Q2 2021 | 2021-06-30 | 0.80 | −0.01 | −1.15% |
| Q4 2020 | 2020-12-31 | 0.90 | −0.15 | −14.01% |
| Q2 2020 | 2020-06-30 | 0.81 | −0.13 | −13.58% |
| Q4 2019 | 2019-12-31 | 1.04 | −0.16 | −13.10% |
| Q2 2019 | 2019-06-30 | 0.94 | −0.21 | −18.04% |
| Q4 2018 | 2018-12-31 | 1.20 | −0.00 | −0.34% |
| Q2 2018 | 2018-06-30 | 1.15 | — | — |
| Q4 2017 | 2017-12-31 | 1.21 | — | — |
Novartis AG current ratio trends
Over the last five fiscal years, Novartis AG's current ratio increased from 0.90 to 1.12, a change of 0.22. The latest reported quarter, Q2 2026, shows 0.86.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novartis AG source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...